![]() |
New to the Huntington's Disease Lighthouse? |
||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 Feb 2010
The European trial of ACR16 yields good results
ACR16 improves voluntary and involuntary movement. This is wonderful news! 31 Jan 2010
A Sirtuin Inhibitor Enters Phase1a Clinical Trials in Europe
Siena Biotech announces a safety and tolerability study with healthy volunteers, preparatory to trials in HD patients. 22 Dec 2009
Synaptic activity, aggregation, and memantine
Normal synaptic activity is neuroprotective, that extrasynaptic activity is toxic, and that memantine will suppress the later while leaving the former unaffected. 22 Dec 2009
Invitation to participate in a quality of life survey
Here is an opportunity to tell the medical professionals about quality of life issues. 6 Dec 2009
An interview with Dr. Jan Nolta
A trial of mesenchymal stem cell is planned for the end of 2010. 5 Dec 2009
Mesenchymal stem cells repair neurotoxin damage in an animal model
Preclinical work supports the use of mesenchymal stem cells to treat neurodegenerative disorders. 5 Dec 2009
Cogane
A new BDNF inducer enters the pipeline. 5 Dec 2009
Track-HD reports baseline findings
Clear differences were found among the control group, premanifest gene carriers, and those in early stages. 5 Dec 2009
The search for genetic modifiers
The search for genetic modifiers is an important part of the effort to find treatments. 5 Dec 2009
The RCAN1 gene and HD
Overexpression of the RCAN1 gene may be a treatment for Huntington All Updates for Home |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclaimer & Privacy
Policy | |
|